Published in Int J Antimicrob Agents on December 01, 2001
Colistin heteroresistance in Enterobacter cloacae is associated with cross-resistance to the host antimicrobial lysozyme. Antimicrob Agents Chemother (2014) 0.93
Assessment of species and antimicrobial resistance among Enterobacteriaceae isolated from mallard duck faeces. Environ Monit Assess (2015) 0.76
Carbapenem- and Colistin-Resistant Enterobacter cloacae from Delta, Colorado, in 2015. Antimicrob Agents Chemother (2016) 0.75
Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother (1985) 5.74
Chromosomal beta-lactamases of Enterobacter cloacae are responsible for resistance to third-generation cephalosporins. Antimicrob Agents Chemother (1983) 5.16
The negative regulator of beta-lactamase induction AmpD is a N-acetyl-anhydromuramyl-L-alanine amidase. FEMS Microbiol Lett (1994) 2.60
Amikacin resistance mediated by multiresistance transposon Tn2424. J Bacteriol (1983) 2.15
Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli. Antimicrob Agents Chemother (1999) 1.99
Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis. Thorax (2009) 1.90
Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin. Antimicrob Agents Chemother (1988) 1.88
The signal molecule for beta-lactamase induction in Enterobacter cloacae is the anhydromuramyl-pentapeptide. Antimicrob Agents Chemother (1997) 1.84
In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia. Antimicrob Agents Chemother (2001) 1.74
Insertions of resistance genes into Tn21-like transposons. J Antimicrob Chemother (1986) 1.70
Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation. Antimicrob Agents Chemother (2007) 1.63
From registry to quality management: the German Cystic Fibrosis Quality Assessment project 1995 2006. Eur Respir J (2007) 1.61
HR 810, a cephalosporin with low affinity for Enterobacter cloacae beta-lactamase. Eur J Clin Microbiol (1983) 1.59
Molecular nature of a streptomycin and sulfonamide resistance plasmid (pBP1) prevalent in clinical Escherichia coli strains and integration of an ampicillin resistance transposon (TnA). Antimicrob Agents Chemother (1981) 1.58
Characterization of Tn2411 and Tn2410, two transposons derived from R-plasmid R1767 and related to Tn2603 and Tn21. J Bacteriol (1983) 1.57
[Stability of coli flora of the healthy human. 1. The occurrence of permanent and changing types]. Arch Hyg Bakteriol (1969) 1.49
Use of a broad-host-range gyrA plasmid for genetic characterization of fluoroquinolone-resistant gram-negative bacteria. Antimicrob Agents Chemother (1991) 1.42
Sequences of wild-type and mutant ampD genes of Citrobacter freundii and Enterobacter cloacae. Antimicrob Agents Chemother (1993) 1.34
Prospective evaluation of emerging bacteria in cystic fibrosis. J Cyst Fibros (2005) 1.33
Beta-lactam antibiotics and selection of resistance: speculation on the evolution of R-plasmids. J Antimicrob Chemother (1986) 1.32
Evolution of Tn21-related transposons: isolation of Tn2425, which harbours IS161. J Gen Microbiol (1985) 1.24
Genetic control of beta-lactamase production in Enterobacter cloacae. Rev Infect Dis (1988) 1.21
Tn21-specific structures in gram-negative bacteria from clinical isolates. Antimicrob Agents Chemother (1992) 1.20
Natural antibiotic susceptibility of Providencia stuartii, P. rettgeri, P. alcalifaciens and P. rustigianii strains. J Med Microbiol (1998) 1.19
Natural antibiotic susceptibility of Enterobacter amnigenus, Enterobacter cancerogenus, Enterobacter gergoviae and Enterobacter sakazakii strains. Clin Microbiol Infect (2002) 1.19
Impact of the ampD gene and its product on beta-lactamase production in Enterobacter cloacae. Rev Infect Dis (1988) 1.18
Natural antibiotic susceptibility of Listeria species: L. grayi, L. innocua, L. ivanovii, L. monocytogenes, L. seeligeri and L. welshimeri strains. Clin Microbiol Infect (2000) 1.16
Characterization of aminoglycoside 6'-N-acetyltransferases [AAC(6')] from gram-negative bacteria and Streptomyces kanamyceticus. J Antimicrob Chemother (1985) 1.14
[The action of ampicillin on the intestinal flora in healthy subjects]. Zentralbl Bakteriol Orig (1965) 1.11
Natural antibiotic susceptibility of Escherichia coli, Shigella, E. vulneris, and E. hermannii strains. Diagn Microbiol Infect Dis (1999) 1.10
Elimination of plasmids by new 4-quinolones. Antimicrob Agents Chemother (1985) 1.08
Mathematical corrections for bacterial loss in pharmacodynamic in vitro dilution models. Antimicrob Agents Chemother (1995) 1.07
Development of resistance in the past decade in central Europe. J Antimicrob Chemother (1986) 1.07
Natural antibiotic susceptibility of strains of Serratia marcescens and the S. liquefaciens complex: S. liquefaciens sensu stricto, S. proteamaculans and S. grimesii. Int J Antimicrob Agents (2003) 1.05
The effect of moxifloxacin on its target topoisomerases from Escherichia coli and Staphylococcus aureus. J Antimicrob Chemother (1999) 1.04
Functional and physiological characterization of the Tn21 cassette for resistance genes in Tn2426. J Gen Microbiol (1993) 1.04
The problems of drug-resistant pathogenic bacteria. Experimental and clinical aspects of resistance determinants. Structure and recipient ability in E. Coli mutants. Ann N Y Acad Sci (1971) 1.03
Chemical characterization and biological activity of Macfadyena unguis-cati (Bignoniaceae). J Pharm Pharmacol (2000) 1.03
Location of N-acetylmuramyl-L-alanyl-D-glutamylmesodiaminopimelic acid, presumed signal molecule for beta-lactamase induction, in the bacterial cell. Antimicrob Agents Chemother (1996) 1.03
Identification and natural antibiotic susceptibility of Morganella morganii. Diagn Microbiol Infect Dis (1998) 1.00
Transposition of a gene encoding OXA-2 beta-lactamase. J Gen Microbiol (1983) 0.98
[The propagation of aminoglycoside transferases in gram negative bacteria]. Int J Clin Pharmacol Biopharm (1979) 0.97
Natural antimicrobial susceptibility patterns and biochemical profiles of Leclercia adecarboxylata strains. Clin Microbiol Infect (2004) 0.96
Mechanisms of antibiotic resistance and their dissemination of resistance genes in the hospital environment. Infect Control (1984) 0.95
An in-vitro study of the antimicrobial susceptibilities of Yersinia enterocolitica and the definition of a database. J Antimicrob Chemother (1999) 0.95
Natural antibiotic susceptibility of Salmonella enterica strains. Int J Antimicrob Agents (2000) 0.93
[The transmission of R factors in the human intestinal flora]. Zentralbl Bakteriol Orig (1970) 0.93
The activity of cefotiam on beta-lactamase-producing bacteria in an in-vitro model. J Antimicrob Chemother (1984) 0.92
Antimicrobial effects of continuous versus intermittent administration of carbapenem antibiotics in an in vitro dynamic model. Antimicrob Agents Chemother (1997) 0.91
Natural antibiotic susceptibility of Rahnella aquatilis and R. aquatilis-related strains. J Chemother (2000) 0.91
Dissemination of streptomycin and sulfonamide resistance by plasmid pBP1 in Escherichia coli. Eur J Clin Microbiol (1983) 0.90
Role of penicillin-binding proteins in the initiation of the AmpC beta-lactamase expression in Enterobacter cloacae. Antimicrob Agents Chemother (2000) 0.89
Antibiotic resistance in intensive care unit areas. Infect Control (1983) 0.88
[The COMOD system. A preservative-free multidose container for eyedrops]. Klin Monbl Augenheilkd (1994) 0.88
[Acute pain management in proximal femoral fractures: femoral nerve block (catheter technique) vs. systemic pain therapy using a clinic internal organisation model]. Anaesthesist (2006) 0.87
Urine bactericidal activity of pefloxacin versus norfloxacin in healthy female volunteers after a single 800-mg oral dose. Infection (1997) 0.87
Application of in-vitro models: development of resistance. J Antimicrob Chemother (1985) 0.87
Transfer of the chromosomal bla gene from Enterobacter cloacae to Escherichia coli by RP4::mini-Mu. J Bacteriol (1984) 0.87
Prevalence of resistance of aerobic gram-negative bacilli to broad-spectrum antibacterial agents: results of a multicentre study. J Antimicrob Chemother (1990) 0.87
Studies on the nature of plasmids arising from conjugation in the human gastro-intestinal tract. J Med Microbiol (1973) 0.87
Natural antibiotic susceptibility of Klebsiella pneumoniae, K. oxytoca, K. planticola, K. ornithinolytica and K. terrigena strains. J Med Microbiol (2001) 0.86
Mobilization of extrachromosomal determinants for streptomycin resistance by transferable colicinogenic factors. Ann N Y Acad Sci (1971) 0.86
The role of N-actylglucosaminyl-1,6 anhydro N-acetylmuramyl-L-alanyl-D-glutamyl-meso-diaminopimelic acid-D-alanine for the induction of beta-lactamase in Enterobacter cloacae. Zentralbl Bakteriol (1996) 0.86
Inhibition of R-plasmid transfer in Escherichia coli by 4-quinolones. Antimicrob Agents Chemother (1987) 0.86
Selection of beta-lactamase producers during cephalosporin and penicillin therapy. Scand J Infect Dis Suppl (1986) 0.85
The incidence and development of resistance in Staphylococcus aureus from three European countries. J Antimicrob Chemother (1984) 0.85
The use of bacteria producing the aminoglycoside inactivating enzyme ANT-(2") in an in-vitro model. J Antimicrob Chemother (1985) 0.85
Bacterial elimination and therapeutic effectiveness under different schedules of amoxicillin administration. Chemotherapy (1981) 0.85
Flow cytometric analysis of nephroblastomas and related neoplasms. Cancer (1986) 0.85
Expression of beta-lactamases in Yersinia enterocolitica strains of biovars 2, 4 and 5. J Med Microbiol (1999) 0.83
[Transmission and inhibition of extrachromosomal drug-resistance factors in the gastrointestinal flora]. Zentralbl Bakteriol Orig A (1972) 0.83
Natural antibiotic susceptibilities of Edwardsiella tarda, E. ictaluri, and E. hoshinae. Antimicrob Agents Chemother (2001) 0.83
Genetic and biochemical basis of resistance of Enterobacteriaceae to beta-lactam antibiotics. J Antimicrob Chemother (1986) 0.83
Natural antimicrobial susceptibilities of Plesiomonas shigelloides strains. J Antimicrob Chemother (2001) 0.83
Antibacterial activity of lomefloxacin in a pharmacokinetic in vitro model. Antimicrob Agents Chemother (1990) 0.83
Tn3 as the molecular basis of ampicillin resistance in E. coli--an epidemiological survey. Zentralbl Bakteriol Mikrobiol Hyg A (1985) 0.82
Multimerization and replication of plasmid pBP11. Plasmid (1982) 0.82
Beta-lactamase expression in Yersinia enterocolitica biovars 1A, 1B, and 3. J Med Microbiol (2000) 0.82
[Rational use of oral antibiotics. Findings of an expert commission of the Paul Ehrlich Society for Chemotherapy]. Med Monatsschr Pharm (2002) 0.81
Natural antibiotic susceptibility of Ewingella americana strains. J Chemother (2003) 0.80
ESGAB breakpoint determination: clarithromycin. Eur J Clin Microbiol Infect Dis (1991) 0.80
Tn2440, a composite tetracycline resistance transposon with direct repeated copies of IS160 at its flanks. J Gen Microbiol (1985) 0.80
Syntheses and biological activities of new N1-aryl substituted quinolone antibacterials. Arch Pharm (Weinheim) (1996) 0.80
[Investigations on the aminoglycoside inactivating enzyme AAC-(6') IV (author's transl)]. Infection (1979) 0.80
[Stablility of Escherichia coli-flora in healthy men. 3. Occurrence of permanent and transitory strains in infants]. Arch Hyg Bakteriol (1971) 0.79
Phenotyping of Staphylococcus aureus reveals a new virulent ST398 lineage. Clin Microbiol Infect (2012) 0.78
Elimination of plasmids by enoxacin and ofloxacin at near inhibitory concentrations. J Antimicrob Chemother (1986) 0.78
R1767, an example of the evolution of resistance plasmids. Plasmid (1985) 0.78
Endovascular therapy of symptomatic intracranial stenosis in patients with impaired regional cerebral blood flow or failure of medical therapy. AJNR Am J Neuroradiol (2007) 0.78
Ambrisentan improves exercise capacity and symptoms in patients with portopulmonary hypertension. Z Gastroenterol (2011) 0.77
Multicenter study of the sensitivity of Pseudomonas aeruginosa to antimicrobial agents. Eur J Clin Microbiol (1985) 0.77
[Drug-induced toxic epidermal necrolysis with involvement of the intestinal and respiratory tract. A case report]. Anaesthesist (2002) 0.77
[Action and reaction. Actions and resistance mechanisms of quinolone]. Pharm Unserer Zeit (2001) 0.77
[Significance of the lipopolysaccharide structure of E. coli for the transmission of R-factors]. Zentralbl Bakteriol Orig A (1972) 0.77
Statistical limitations of percent ideal body weight as measure for nutritional failure in patients with cystic fibrosis. J Cyst Fibros (2009) 0.77
Increased clearance of low density lipoprotein precursors in patients with heterozygous familial defective apolipoprotein B-100: a stable isotope approach. J Lipid Res (1996) 0.77
Clinical significance and spread of fluoroquinolone resistant uropathogens in hospitalised urological patients. Infection (1994) 0.77
Inhibitory effects of baeomycesic acid from the lichen Thamnolia subuliformis on 5-lipoxygenase in vitro. Phytomedicine (1997) 0.76